TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT05934487: A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients

Sponsor: Endotronix, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 1750 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$7,138,000

Rescue Site Savings

+$4,714,400

Unlock Full NCT05934487 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05934487 Rescue Dossier →